Suven Life Sciences achieved 100% patient enrolment in Phase-2b clinical trial of Ropanicant for MDO
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
It's an acquisition that aims at forming one of the US's largest oncology trial networks
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
AGA affects up to 80 per cent of men across their lifetime and remains one of the most common and most psychologically challenging forms of hair loss
This collaboration turns kitting into a strategic advantage for sponsors and sites
The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
FIBROSARC did not meet its primary PFS endpoint in the final analysi
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
Subscribe To Our Newsletter & Stay Updated